Silence Therapeutics saw the highest growth of 0.59% in patent filings in April and 6.99% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.59% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Silence Therapeutics’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Silence Therapeutics has been focused on protecting inventions in Israel(IL) with four publications in Q2 2024
The Israel(IL) Patent Office dominates the patent filings and grants with nearly 20% filings and 33% grants. The Israel(IL), Japan(JP), United States(US), and Australia(AU) patent Office are among the top ten patent offices where Silence Therapeutics is filings its patents. Among the top granted patent authorities, Silence Therapeutics has 33% of its grants in Israel(IL), 22% in Japan(JP) and 22% in Australia(AU).
Arrowhead Pharmaceuticals and Novo Nordisk Foundation could be the strongest competitors for Silence Therapeutics
Patents related to rare diseases lead Silence Therapeutics's portfolio
Silence Therapeutics has the highest number of patents in rare diseases. For rare diseases no patents were filed and 100% of patents were granted in Q2 2024.
Cardiovascular disease related patents lead Silence Therapeutics portfolio followed by stroke, and aortic valve stenosis
Silence Therapeutics has highest number of patents in cardiovascular disease followed by stroke, aortic valve stenosis, atypical hemolytic uremic syndrome (nondiarrhea - associated hemolytic uremic syndrome), and hemochromatosis.
For comprehensive analysis of Silence Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
